Cannabis Law Report

JUNE 5, 2019

Press Release: Thailand Government Pharmaceutical Organization. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

CannaTech

SEPTEMBER 23, 2019

The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.

Patients 79

Patients Policy Clinical Trials Research and Development 79

Puff Puff Post

MARCH 10, 2020

SOURCE InMed Pharmaceuticals Inc. InMed has conducted preclinical pharmacology studies that suggest CBN in INM-755 may help relieve hallmark EB symptoms, including inflammation and pain, as well potentially restore the integrity of the skin in a subset of EB Simplex patients.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

Cannabis Law Report

JUNE 22, 2021

2021 /CNW/ – Halo Collective Inc. (“Halo”) (NEO: HALO) (OTCQX: HCANF) (Germany: A9KN), a vertically integrated multinational cannabis company, today announced that its board of directors has unanimously approved the reorganization (the “International Reorganization”) of its non-U.S. TORONTO , June 22,?2021

Collective 64

Collective Research and Development Cultivation Cannabis 64

Cannabis Law Report

NOVEMBER 9, 2021

Akanda launches with two key assets, CanMart and Bophelo, bringing pharmaceutical grade cannabis from Africa to supply UK, European and other international markets. CanMart”) from Halo Collective Inc. (“Halo”) (NEO: HALO) (OTCQB: HCANF) (Germany: A9KN). Bophelo”) and CanMart Ltd.

Collective 52

Collective Supply Chain Seed-To-Sale Events 52

Cannabis Law Report

APRIL 28, 2022

DEMECAN’s first cannabis shipment to the BfArM is ready for collection and includes more than 100 kg of cannabis flowers. High-quality cannabis flowers from DEMECAN’s German high-end facility are now available to patients. 2500 cannabis plants are now growing in its own flower rooms in Saxony.

Pharmaceutical 52

Pharmaceutical Cultivation Collective Patients 52

Cannabis Law Report

AUGUST 20, 2021

Bophelo is being spun off by Canadian parent Halo Collective into a new, non-US, international entity, Akanda. CNW Group/Halo Collective Inc.). . … The suits have descended on Lesotho to start putting a value on Bophelo Bioscience and Wellness , which aspires to be the world’s biggest cannabis grow. Europe, and beyond.”.

Collective 105

Collective Banking Pharmaceutical Cultivation 105

FloridaMarijuana.net

JULY 16, 2018

No need to take pills that could do more harm than good; or deal with painful side effects that pharmaceuticals cause. Patients that are seeking a natural and alternative medicine to the condition they are facing can register for a medical marijuana card by starting here. Patient intake form. I felt free from my ailment.

Marijuana 189

Marijuana Patients Conditions Treatment 189

Cannabis Law Report

FEBRUARY 18, 2022

We are one of the first to successfully complete a commercial shipment of Colombian-manufactured high-CBD pharmaceutical product to Germany available for patients in pharmacies under prescription. Ethypharm aspires to work closely with doctors and pharmacists to improve patients’ lives.

Extraction 52

Extraction Pharmaceutical Patients Cannabinoids 52

The Cannigma

APRIL 12, 2023

In September 2021, MoreBetter hosted a self-reported data collection with this CBN tincture offered to participants for free of charge from CBDistillery. Interestingly, unlike many formal clinical studies, participants in this data collection skewed female, with 196 women and 87 men. MoreBetter also hosts data collection studies.

Sleep 133

Sleep Data Tincture Research and Development 133

United Patients Group

JANUARY 4, 2024

As we move forward into 2024 and beyond, the sector offers diverse paths beyond direct patient care. The growth stems from rising healthcare demand, facility expansion, and the imperative for efficient administration to maintain quality patient care. Adverse drug events (ADEs) affect approximately 7 per 100 hospitalized patients.

Research and Development 52

Research and Development Patients Data Policy 52

Canna Care Docs

SEPTEMBER 18, 2020

Patients under the age of 18 must also have a parent or guardian registered as a caregiver on their behalf. Patients may purchase a 90 day supply of their medication. Patients may purchase medical cannabis in oil-based preparations such as lozenges, capsules, and vape pens. Can a Qualifying Patient Grow Cannabis in Virginia?

Pharmaceutical 98

Pharmaceutical Conditions Patients Oil 98

United Patients Group

MAY 17, 2023

collecting items related to trains). Recently, a pharmaceutical company has created a cannabis based isolate, meaning one cannabinoid, in this case CBD called Epidiolex which is available by prescription in all 50 states. Emotions and Behaviors Autism spectrum disorder (ASD) is a spectrum disorder that affects people in different ways.

Sleep 81

Sleep Cannabinoids Patients CBD 81

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

JUNE 21, 2021

Pharmaceutical companies use artificial intelligence (AI) to sort through reams of scientific data to find potentially effective active ingredients to be developed into approved drugs. The most recent one , from June 2021, takes a look at patients using cannabis to relieve pain. The report further breaks down use by specific cultivars.

Data 105

Data Clinical Trials Research and Development Indica 105

Cannabis Law Report

AUGUST 2, 2021

OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain. TEL AVIV, Israel , Aug. ” About The Study.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

FloridaMarijuana.net

JUNE 27, 2018

Participants in the study recorded their personal experience when using cannabis for their depression and other mental conditions such as anxiety and stress; scientists were able to use data collected from the app to analyze the results. Antidepressants alter the balance of chemicals in the brain to relieve symptoms of depression.

Treatment 100

Treatment Marijuana Conditions Data 100

Cannabis Law Report

JULY 21, 2021

Tryp will seek to identify a response in patients to the treatment to inform the design of a Phase 2b clinical trial for fibromyalgia that will use the company’s proprietary, psilocybin-based drug product, TRP-8803, that includes a novel formulation and unique method of delivery. San Diego, California–(Newsfile Corp.

Clinical Trials 105

Clinical Trials Chronic Pain Research and Development Treatment 105

Cannabis Law Report

SEPTEMBER 29, 2022

Medicinal cannabis companies that falsely claimed their prescription products could treat serious conditions, such as cancer and epilepsy, have received a collective fine of almost $1m by Australia’s drugs regulator. Three medicinal cannabis companies fined almost $1 million for alleged unlawful advertising. 27 September 2022.

Epilepsy 52

Epilepsy Conditions Media Medicine 52

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. billion, servicing nearly 340,000 active patients. In 2019, the island’s economy grew by 2.1% in real terms to £4.97 to reach 3.2

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

DECEMBER 22, 2019

On April 22, 2019, United Nations-based cannabis correspondent and global drug policy analyst Sara Brittany Somerset took advantage of our collective national climate focus to address the “ cannabis carbon footprint ” issue with her pertinent Earth Day Begs The Question: Is Cannabis Farming Sustainable?

Packaging 96

Packaging Seed-To-Sale Agriculture Environment 96

Cannabis Law Report

AUGUST 3, 2021

Unlike most other ailments, there isn’t a simple test that physicians can use to diagnose a patient with a disorder. Many mental health disorders have treatment options, but they aren’t nearly as safe and efficacious as conventional pharmaceuticals or therapies. Medxtractor Corp. compound annual growth rate from $2.8

Research and Development 105

Research and Development Data Conditions Therapy 105

Cannabis Law Report

JULY 19, 2021

The data from the study is expected to be embedded into the RYAH MD platform, with the goal of enabling healthcare professionals to administer THC, CBD and terpenes in milliliters, which are then expected to automatically be converted into milligrams to allow for a customized, targeted patient inhalation session. billion by 2027.

Therapy 76

Therapy Data Research and Development Events 76

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Patients are unclear on what product to choose and healthcare providers don’t yet have the data to counsel on proper dosage.”. brands, including Lord Jones.

CBD 105

CBD Data Sleep Clinical Trials 105

The Cannigma

FEBRUARY 11, 2021

One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them. All of that data is packaged into software doctors can use to manage their patients’ medical marijuana treatment. “I I know how to collect data. I know how to analyze data.

Wellness and Beauty 125

Wellness and Beauty Data Patients Medicine 125

Cannabis Law Report

MARCH 22, 2020

Aurelius Data, a company dedicated to providing data around plant-based medicines, warned the public Tuesday that THC and COVID-19 don’t mix, based on what they know about how cannabinoids affect patients with influenza. Additional research is also needed to determine if THC is in fact harmful to coronavirus patients.

THC 59

THC Clinical Trials Data Consumption 59

Cannabis Law Report

OCTOBER 5, 2021

“This scientific and commercial excitement rests on research showing that psychedelics can supercharge mental health treatment for PTSD, depression, anxiety, addiction, and other chronic ailments of the mind, enabling patients to dive deep, confront their traumas and — a rarity for mental illnesses — return healed,” the article reads.

Therapy 52

Therapy Pharmaceutical Collective Treatment 52

Veriheal

OCTOBER 29, 2020

Is the focus on the negative impact due to the fact that role players want cannabis to remain illicit as to avoid its potential role in replacing pharmaceutical medication? Scenario 2: Pharmaceuticals. However, the focus of funding remains on negative impacts. How could we move the focus towards understanding the benefits?

Pharmaceutical 98

Pharmaceutical Therapy Cannabinoids Chronic Pain 98

SpeedWeed

JULY 19, 2021

High Times was contacted by cannabis warrior and concerned advocate Amy Smoot, who gave testimony at this meeting on behalf of three different families who had young children who couldn’t be treated with traditional pharmaceutical medications. I see cannabis being used as an exit from dangerous and harmful pharmaceuticals.

Pharmaceutical 52

Pharmaceutical Patients Legislation Medicine 52

Cannabis Law Report

JULY 28, 2021

This direct access to patients and clinics is expected to differentiate KGK from other CROs by providing the opportunity to study patients with differing demographics across various populations, while also shortening recruitment timelines for studies. The recent addition of KGK Science Inc. On behalf of: KETAMINE ONE.

Clinical Trials 81

Clinical Trials Research and Development Treatment Therapy 81

CannaMD

JULY 23, 2020

In the novel study conducted by researchers at the University of New Mexico, nearly 2,000 people self-administered cannabis over a three-year period and reported their marijuana use via the Releaf App that was specifically designed for the study’s data collection needs. Don’t have time to call? Find Out if You Qualify.

Data 89

Data Chronic Pain Sleep Patients 89

Veriheal

JANUARY 12, 2023

The law also permits the agricultural production of cannabis and hemp for industrial purposes, with a heavy emphasis on pharmaceutical crops. . This idyllic overseas collectivity of France is famous for its water-floating bungalow hotels, mountainous backdrops, and plunging waterfalls.

Medicine 95

Medicine Chronic Pain Consumption Cannabis 95

SpeedWeed

MAY 17, 2021

Martin’s cannabis use is completely legal under state law, though – he is a state-certified medical marijuana patient who has been using cannabis to treat chronic back pain and PTSD. At this point, the fire department terminated his employment, based on the rules of his union’s collective bargaining agreement.

Legalization 52

Legalization Chronic Pain Collective State Laws 52

SpeedWeed

AUGUST 11, 2021

Veterans are demanding objective cannabis drug development research, and the state of Michigan is fulfilling our collective obligation to our beloved Veteran community.”. Results of this study showed evidence of the pros and cons to cannabis as a treatment for PTSD patients. The study was funded with $2.2

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical DEA 52

Cannabis Law Report

JUNE 28, 2021

He has held various executive leadership positions, including heading up research and development and driving the scientific strategy at Bayer Pharmaceuticals as well as Wyeth Pharmaceuticals, where he was appointed interim President and general manager in 2008.

Research and Development 76

Research and Development Pharmaceutical Therapy Sleep 76

Cannabis Law Report

NOVEMBER 9, 2021

We do worry about collective memory in this day and age. The legislation would grandfather existing state-licensed cannabis operators into the federal scheme to ensure continued patient access and incentivize participation in the legal market. -As According to MM the proposed legislation suggests the following.

Media 52

Media Legalization Marijuana Agriculture 52

Cannabis Law Report

JULY 19, 2021

Provide strategic recruitment that incorporates a diverse population (diversity is currently lacking in psychedelic research to date) with a database of 1 million+ patients in Canada and 15 million+ globally. MONTREAL & CALGARY, Alberta & TORONTO–(BUSINESS WIRE)– #biotechnology –Knowde Group Inc. ,

Clinical Trials 98

Clinical Trials Research and Development Hybrid Medicine 98